Occult hepatitis B virus infection and its clinical implications
- 25 June 2002
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 9 (4) , 243-257
- https://doi.org/10.1046/j.1365-2893.2002.00344.x
Abstract
Occult hepatitis B virus (HBV) infection is characterized by presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg). Serum HBV level is usually less than 104 copies/mL in these patients. Diagnosis of occult HBV infection requires sensitive HBV‐DNA PCR assay. Several possibilities have been hypothesized as the mechanisms of occult HBV infection. These include: (i) mutations of HBV‐DNA sequence; (ii) integration of HBV‐DNA into host's chromosomes; (iii) infection of peripheral blood mononuclear cells by HBV; (iv) formation of HBV‐containing immune complex; (v) altered host immune response; and (vi) interference of HBV by other viruses. The precise prevalence of occult HBV infection remains to be defined. The clinical implications of occult HBV infection involve different clinical aspects. First of all, occult HBV infection harbours potential risk of HBV transmission through blood transfusion, haemodialysis, and organ transplantation. Second, it may serve as the cause of cryptogenic liver disease, contribute to acute exacerbation of chronic hepatitis B, or even fulminant hepatitis. Third, it is associated with development of hepatocellular carcinoma. Fourth, it may affect disease progression and treatment response of chronic hepatitis C. Most of the previous studies utilized retrospective observation without control groups, and lacked direct association of occult HBV infection with specific pathological changes and disease progression. Highly sensitive, quantitative, and functional molecular analyses of HBV, combined with a well‐designed prospective clinical assessment will provide the best approach for the future study of occult HBV infection.Keywords
This publication has 104 references indexed in Scilit:
- Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfectionArchiv für die gesamte Virusforschung, 1997
- Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infectionJournal of Hepatology, 1997
- Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reactionJournal of Hepatology, 1996
- Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis BDigestive Diseases and Sciences, 1995
- Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinomaEuropean Journal of Epidemiology, 1994
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990
- Hepatitis B: global importance and need for controlVaccine, 1990
- Hepatitis B virus DNA in mononuclear blood cellsJournal of Hepatology, 1986
- Hepatitis B Virus DNA in Patients with Chronic Liver Disease and Negative Tests for Hepatitis B Surface AntigenNew England Journal of Medicine, 1985
- Hepatitis B virus multiplication in the absence of usual serological markersJournal of Hepatology, 1985